Brian Webster is the President, Chief Executive Officer, and Director at Kestra Medical Technologies Ltd., a leader in wearable cardiac technology dedicated to preventing sudden cardiac arrest. With more than 25 years of executive experience in the medical device industry, Brian has a proven track record of driving innovation, commercialization, and growth in cardiology and minimally invasive therapies. His strategic vision has consistently transformed early-stage companies into market contenders through successful funding rounds, regulatory approvals, and global expansions. Prior to joining Kestra in 2020, Brian served as President and CEO of NuAxia Medical Technologies, where he advanced percutaneous facet fusion systems for spine care. He previously held senior leadership roles at BioVentrix Inc. as Executive Vice President of Sales and Marketing, focusing on left ventricular repair devices; at CardioKinetix Inc., leading sales for septal occlusion technologies; and at ev3 Inc., building vascular intervention franchises. Among his notable achievements are securing over $150 million in venture capital, achieving multiple FDA clearances, and scaling sales teams to exceed $100 million in annual revenue. At Kestra, Brian oversees all aspects of the company's operations, including the development and global rollout of the ASSURE Wearable Cardioverter Defibrillator System—the lightest and most comfortable WCD on the market. Under his leadership, Kestra has obtained key regulatory approvals, forged strategic partnerships, and positioned the company for sustained growth in patient-centric cardiac protection solutions.